Annual Operating Expenses
$30.38 B
+$2.98 B+10.87%
31 December 2023
Summary:
AstraZeneca annual total operating expenses is currently $30.38 billion, with the most recent change of +$2.98 billion (+10.87%) on 31 December 2023. During the last 3 years, it has risen by +$12.98 billion (+74.57%). AZN annual operating expenses is now at all-time high.AZN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$8.38 B
+$369.00 M+4.61%
30 September 2024
Summary:
AstraZeneca quarterly total operating expenses is currently $8.38 billion, with the most recent change of +$369.00 million (+4.61%) on 30 September 2024. Over the past year, it has increased by +$935.00 million (+12.56%). AZN quarterly operating expenses is now -5.58% below its all-time high of $8.87 billion, reached on 31 December 2021.AZN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.9% | +12.6% |
| 3 y3 years | +74.6% | +7.6% |
| 5 y5 years | +82.6% | +94.9% |
AZN Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.6% | -5.6% | +31.0% |
| 5 y | 5 years | at high | +82.6% | -5.6% | +135.3% |
| alltime | all time | at high | +496.8% | -5.6% | +1113.5% |
AstraZeneca Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.38 B(+4.6%) |
| June 2024 | - | $8.01 B(+9.0%) |
| Mar 2024 | - | $7.35 B(+6.1%) |
| Dec 2023 | $30.38 B(+10.9%) | $6.92 B(-7.0%) |
| Sept 2023 | - | $7.44 B(+6.3%) |
| June 2023 | - | $7.00 B(+5.0%) |
| Mar 2023 | - | $6.67 B(+4.2%) |
| Dec 2022 | $27.40 B(+9.1%) | $6.40 B(-5.3%) |
| Sept 2022 | - | $6.75 B(-6.6%) |
| June 2022 | - | $7.23 B(+3.3%) |
| Mar 2022 | - | $7.00 B(-21.1%) |
| Dec 2021 | $25.11 B(+44.3%) | $8.87 B(+14.0%) |
| Sept 2021 | - | $7.78 B(+58.8%) |
| June 2021 | - | $4.90 B(+37.7%) |
| Mar 2021 | - | $3.56 B(-36.9%) |
| Dec 2020 | $17.40 B(-1.8%) | $5.64 B(+39.8%) |
| Sept 2020 | - | $4.04 B(+0.7%) |
| June 2020 | - | $4.01 B(+7.9%) |
| Mar 2020 | - | $3.71 B(-37.0%) |
| Dec 2019 | $17.73 B(+6.5%) | $5.89 B(+37.2%) |
| Sept 2019 | - | $4.30 B(+0.7%) |
| June 2019 | - | $4.27 B(+30.7%) |
| Mar 2019 | - | $3.27 B(-51.8%) |
| Dec 2018 | $16.64 B(+3.4%) | $6.77 B(+106.7%) |
| Sept 2018 | - | $3.27 B(-3.1%) |
| June 2018 | - | $3.38 B(+1.0%) |
| Mar 2018 | - | $3.35 B(-39.0%) |
| Dec 2017 | $16.09 B(+5.2%) | $5.49 B(+43.2%) |
| Sept 2017 | - | $3.83 B(+20.7%) |
| June 2017 | - | $3.18 B(-11.6%) |
| Mar 2017 | - | $3.59 B(+11.5%) |
| Dec 2016 | $15.30 B(-9.9%) | $3.22 B(-14.6%) |
| Sept 2016 | - | $3.77 B(-11.0%) |
| June 2016 | - | $4.24 B(+4.1%) |
| Mar 2016 | - | $4.07 B(-20.0%) |
| Dec 2015 | $17.00 B(-7.2%) | $5.09 B(+36.3%) |
| Sept 2015 | - | $3.73 B(-13.5%) |
| June 2015 | - | $4.32 B(+12.0%) |
| Mar 2015 | - | $3.85 B(-25.1%) |
| Dec 2014 | $18.32 B(+8.7%) | $5.14 B(+10.6%) |
| Sept 2014 | - | $4.65 B(+7.1%) |
| June 2014 | - | $4.35 B(+4.2%) |
| Mar 2014 | - | $4.17 B(-31.7%) |
| Dec 2013 | $16.85 B(+14.6%) | $6.10 B(+84.6%) |
| Sept 2013 | - | $3.31 B(-11.0%) |
| June 2013 | - | $3.71 B(-0.2%) |
| Mar 2013 | - | $3.72 B(-11.0%) |
| Dec 2012 | $14.70 B(-9.8%) | $4.18 B(+28.6%) |
| Sept 2012 | - | $3.25 B(-5.6%) |
| June 2012 | - | $3.45 B(-9.6%) |
| Mar 2012 | - | $3.81 B(-40.3%) |
| Dec 2011 | $16.29 B(+6.3%) | $6.39 B(+171.1%) |
| Sept 2011 | - | $2.36 B(-40.8%) |
| June 2011 | - | $3.98 B(+12.1%) |
| Mar 2011 | - | $3.55 B(-19.1%) |
| Dec 2010 | $15.33 B | $4.39 B(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $3.97 B(+7.5%) |
| June 2010 | - | $3.69 B(+12.6%) |
| Mar 2010 | - | $3.28 B(-40.5%) |
| Dec 2009 | $16.04 B(+1.1%) | $5.51 B(+47.5%) |
| Sept 2009 | - | $3.73 B(+2.5%) |
| June 2009 | - | $3.64 B(+15.5%) |
| Mar 2009 | - | $3.15 B(-29.0%) |
| Dec 2008 | $15.86 B(+5.4%) | $4.45 B(+21.5%) |
| Sept 2008 | - | $3.66 B(-6.7%) |
| June 2008 | - | $3.92 B(+2.3%) |
| Mar 2008 | - | $3.83 B(-18.5%) |
| Dec 2007 | $15.05 B(+18.5%) | $4.70 B(+31.5%) |
| Sept 2007 | - | $3.58 B(+3.5%) |
| June 2007 | - | $3.46 B(+4.4%) |
| Mar 2007 | - | $3.31 B(-7.4%) |
| Dec 2006 | $12.70 B(+5.0%) | $3.57 B(+16.3%) |
| Sept 2006 | - | $3.07 B(-2.7%) |
| June 2006 | - | $3.16 B(+8.9%) |
| Mar 2006 | - | $2.90 B(-11.1%) |
| Dec 2005 | $12.09 B(+3.5%) | $3.26 B(+14.5%) |
| Sept 2005 | - | $2.85 B(-8.1%) |
| June 2005 | - | $3.10 B(+7.7%) |
| Mar 2005 | - | $2.88 B(-5.0%) |
| Dec 2004 | $11.69 B(+12.6%) | $3.03 B(+7.9%) |
| Sept 2004 | - | $2.81 B(-6.0%) |
| June 2004 | - | $2.98 B(+4.2%) |
| Mar 2004 | - | $2.86 B(-7.0%) |
| Dec 2003 | $10.38 B(+11.4%) | $3.08 B(+22.5%) |
| Sept 2003 | - | $2.51 B(+2.4%) |
| June 2003 | - | $2.45 B(+5.3%) |
| Mar 2003 | - | $2.33 B(-20.6%) |
| Dec 2002 | $9.31 B(+18.4%) | $2.94 B(+31.5%) |
| Sept 2002 | - | $2.23 B(+2.1%) |
| June 2002 | - | $2.19 B(+11.9%) |
| Mar 2002 | - | $1.96 B(-8.8%) |
| Dec 2001 | $7.87 B(-42.3%) | $2.14 B(+14.6%) |
| Sept 2001 | - | $1.87 B(-8.6%) |
| June 2001 | - | $2.05 B(+8.8%) |
| Mar 2001 | - | $1.88 B(-76.0%) |
| Dec 2000 | $13.64 B(+61.3%) | $7.83 B(+311.9%) |
| Sept 2000 | - | $1.90 B(-4.4%) |
| June 2000 | - | $1.99 B(+3.3%) |
| Mar 2000 | - | $1.92 B(+11.4%) |
| Dec 1999 | $8.46 B(+23.3%) | $1.73 B(-18.4%) |
| Sept 1999 | - | $2.12 B(-8.1%) |
| June 1999 | - | $2.31 B(+37.2%) |
| Dec 1998 | $6.86 B(+1.3%) | - |
| June 1998 | - | $1.68 B(+143.3%) |
| Dec 1997 | $6.77 B(-7.4%) | - |
| Dec 1996 | $7.32 B(+24.3%) | - |
| Dec 1995 | $5.89 B(+1.3%) | - |
| June 1995 | - | $690.40 M |
| Dec 1994 | $5.81 B(+4.7%) | - |
| Dec 1993 | $5.55 B(+9.0%) | - |
| Dec 1992 | $5.09 B(-16.3%) | - |
| Dec 1991 | $6.08 B(+0.7%) | - |
| Dec 1990 | $6.04 B | - |
FAQ
- What is AstraZeneca annual total operating expenses?
- What is the all time high annual operating expenses for AstraZeneca?
- What is AstraZeneca annual operating expenses year-on-year change?
- What is AstraZeneca quarterly total operating expenses?
- What is the all time high quarterly operating expenses for AstraZeneca?
- What is AstraZeneca quarterly operating expenses year-on-year change?
What is AstraZeneca annual total operating expenses?
The current annual operating expenses of AZN is $30.38 B
What is the all time high annual operating expenses for AstraZeneca?
AstraZeneca all-time high annual total operating expenses is $30.38 B
What is AstraZeneca annual operating expenses year-on-year change?
Over the past year, AZN annual total operating expenses has changed by +$2.98 B (+10.87%)
What is AstraZeneca quarterly total operating expenses?
The current quarterly operating expenses of AZN is $8.38 B
What is the all time high quarterly operating expenses for AstraZeneca?
AstraZeneca all-time high quarterly total operating expenses is $8.87 B
What is AstraZeneca quarterly operating expenses year-on-year change?
Over the past year, AZN quarterly total operating expenses has changed by +$935.00 M (+12.56%)